Search Results for "Breast Pap Test Trial"

23:11 EST 21st February 2017 | BioPortfolio

Matching Channels

Sniff test

Schilling test

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Breast Lumps


At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Matching News

Carbone clinical trials test dietary therapy for triple-negative breast cancer

(University of Wisconsin-Madison) A new clinical trial for women with clinically aggressive triple-negative breast cancer (TNBC) will test a novel theory: Will a diet low in an essential nutrient make...

Experts present triple-negative breast cancer immunotherapy trial

A researcher from University Hospitals Seidman Cancer Center will discuss his upcoming immunotherapy clinical trial for triple-negative breast cancer at the 2016 San Antonio Breast Cancer Symposium. T...

Everolimus extends PFS for HR positive, HER2 negative breast cancer

Dr Kornblum speaks with ecancer at the San Antonio Breast Cancer Symposium 2016 about results from the PrECOB 0102 trial, a randomised, double-blind phase II trial of everolimus vs placebo in combin...

UH Seidman cancer center expert presents triple-negative breast cancer immunotherapy trial

(University Hospitals Cleveland Medical Center) A researcher from UH Seidman Cancer Center will discuss his upcoming immunotherapy clinical trial for triple-negative breast cancer at 2016 San Antonio ...

Scientists developing new test for breast cancer

Scientists at The Australian National University (ANU) are working with researchers in France to develop a new potential way to detect and monitor breast cancer that could involve a simple blood test.

FALCON Breast Cancer Trial: Who's Naive Here?

In the FALCON trial, fulvestrant improved PFS in ER+ metastatic breast cancer patients who were endocrine-therapy naive, but the trial failed to answer key clinical questions, says Dr Lidia Schapira. ...

TEAM IIb trial results: Adjuvant ibandronate in early breast cancer

Prof Linn presents data at the 2016 San Antonio Breast Cancer Symposium from the TEAM IIb trial, in which post-menopausal women with hormone receptor positive breast cancer, with no metastases, wer...

Common breast cancer test may not be worth the cost, study suggests

A new study by a UCLA researcher in collaboration with colleagues at Harvard and University of Texas Southwestern has found that a genomic test widely used to help determine whether women with a commo...

Matching PubMed Articles

Prognostic Factors For Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.

Prognostic factors of ipsilateral breast tumor recurrence (IBTR) may change over time following breast-conserving therapy.

A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer.

Glucocorticoid receptor (GR) overexpression is associated with poor prognosis ER-negative breast cancer. GR antagonism with mifepristone increases chemotherapy-induced breast cancer cell death, theref...

Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer.

Accelerated partial breast irradiation (APBI) is emerging as an alternative to whole-breast irradiation. This study presents the results of a prospective trial evaluating 3-dimensional conformal radio...

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer.

SUPREMO is a phase 3 randomised trial evaluating radiotherapy post-mastectomy for intermediate-risk breast cancer. 1688 patients were enrolled from 16 countries between 2006 and 2013. We report the re...

Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients.

The ACOSOG Z0011 trial, a randomized controlled trial among patients with sentinel node positive breast cancer treated with breast conserving therapy, concluded that axillary lymph node dissection (AL...

Search Whole site using Google

Quick Search
Advertisement Advertisement